menu
Streptozocin Market Size, Share, Outlook, and Opportunity Analysis, 2018– 2026
Streptozocin Market Size, Share, Outlook, and Opportunity Analysis, 2018– 2026
Streptozocin Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.

StreptozocinMarket by Product Type (Powder and Solution), by Distribution Channel(Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and byGeography (North America, Europe, Asia Pacific, Latin America, Middle East, andAfrica) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

Streptozocin is a drug approvedby U.S. Food and Drug Administration (USFDA) for the treatment of pancreaticislet cells cancer. Streptozocin is classified as an alkylating agent, whichproduces anti-cancer effects by causing a chemical reaction that damages theDNA in a cell.  The DNA damage caused bystreptozocin results in the cell death. Streptozocin damages pancreatic cellscausing hyperglycemia, so, also used in medical research to produce an animalmodel for hyperglycemia.

Streptozocin Market– Driver

Increasing research activitiesusing streptozocin is expected to propel growth of the streptozocin marketduring the forecast period. For instance, an article published in the journalNature in February 2018, stated that streptozocin may reduce the virulence ofStaphylococcus aureus. It is a Gram-positive human pathogen, which colonizes atskin and other mucosal surface and causes various diseases ranging from skinand soft-tissue infections, endocarditis, toxic shock syndrome, and necrotizingpneumonia. The virulence gene in the bacteria can be targeted by streptozocin.

* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2312

Streptozocin Market– Restraint

Shortages of streptozocin in theglobal market during the forecast period my affect the growth of streptozocinin global market. For instance, according to Drug Shortages of Canada in March2017, Zanosar sterile powder for solution manufactured by PALADIN LABS INC.,containing streptozocin was on shortage in 2017. The drug was manufactured byFurthermore, rising prevalence of kidney diseases are negatively inhibiting thegrowth of streptozocin in global market since streptozocin is contraindicatedin the kidney diseases due to renal toxicity. For instance, according tonational Institute of Diabetes and Digestive and Kidney Diseases, of U.S., in2015, overall prevalence of Chronic Kidney Disease (CKD) in the generalpopulation in U.S. was around 14 percent in 2015, which my hamper growth of thestreptozocin market.

Streptozocin Market– RegionalAnalysis

On the basis of region, theglobal streptozocin market is segmented into North America, Latin America,Europe, Asia Pacific, Middle East, and Africa.

Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/streptozocin-market-2312

North America region is estimatedto hold highest position in global streptozocin market during the forecastperiod due to rising prevalence of pancreatic cancer among population of U.S.For instance, according to National Cancer Institute 2015 statistics, an estimated68,615 people were living with pancreatic cancer in the U.S. and about 55,440new cases are estimated to be diagnosed with pancreatic cancer during 2018.

Asia Pacific is projected towitness significant growth in the global streptozocin market during theforecast period, owing to increasing awareness regarding pancreatic cancer andits management. For instance, in November 2017, PanCAN organized Purple Stridecharity run and walk event, which aimed to increase awareness regardingpancreatic cancer. PanCAN is a nonprofit network in Japan for people fightingwith pancreatic cancer. Japan Pancreatic Cancer Action Network (PanCAN Japan)organizes November as a Pancreatic Cancer Awareness Month.

Key players operating instreptozocin market include Sigma-Aldrich, Inc., LGM Pharma., Xiamen HisunnyChemical Co Ltd, Beijing Yunbang Biosiciences Co Ltd, Neostar United IndustrialCo Ltd, Haihang Industry Co Ltd, Shaanxi Top Pharm Chemical Co Ltd, and ChengduYuyang High-Tech Developing Co Ltd.

Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2312

AboutCoherent Market Insights:            

CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.

ContactUs:

mailto:sales@coherentmarketinsights.com

U.S.Office:

Name:  Mr. Shah

CoherentMarket Insights 1001 4th Ave,

# 3200Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN:  +050-5539-1737